Back to LGND Stock Lookup

LGND –

Apr 16, 2014 03:50 PM Ligand Pharmaceuticals (LGND) Shoots Higher on Volume
Apr 11, 2014 04:46 PM Form 8-K LIGAND PHARMACEUTICALS For: Apr 09
Mar 26, 2014 07:29 PM Form 4 LIGAND PHARMACEUTICALS For: Mar 24 Filed by: LAMPERT MARK N
Mar 24, 2014 01:02 PM UPDATE: Brinson Patrick Starts Ligand Pharma (LGND) at Market Outperform
Mar 20, 2014 06:41 PM Form 4 LIGAND PHARMACEUTICALS For: Mar 18 Filed by: Davis Todd C
Mar 20, 2014 06:40 PM Form 4 LIGAND PHARMACEUTICALS For: Mar 18 Filed by: LAMATTINA JOHN L
Mar 18, 2014 02:50 PM Roth Still Bullish on Ligand Pharma (LGND) Following NOXAFIL Approval (MRK)
Mar 17, 2014 08:15 AM Ligand Earns $1 Million Milestone Payment Triggered by FDA Approval of Merck’s NOXAFIL® (posaconazole) Injection for Intravenous Use, a New Captisol-enabled Formulation
Mar 13, 2014 09:35 AM Ligand Pharma (LGND) Target Up to $91 at Summer Street
Mar 11, 2014 04:15 PM Ligand Announces Highlights from Presentation at the 26th Annual Roth Capital Conference
Mar 10, 2014 10:12 AM Captisol® Licensee Lundbeck Announces FDA Acceptance of NDA Submission for Carbamazepine IV
Feb 28, 2014 12:19 PM Roth Still Positive on Ligand (LGND) Following Promacta sNDA Submission
Feb 28, 2014 11:54 AM Ligand Pharma (LGND), Glaxo (GSK) Submit sNDA for Promacta to FDA
Feb 28, 2014 11:38 AM Form 4 LIGAND PHARMACEUTICALS For: Feb 27 Filed by: Sabba Stephen L
Feb 28, 2014 09:57 AM Ligand Partner GlaxoSmithKline Submits U.S. Regulatory Application for Promacta® (eltrombopag) for Severe Aplastic Anaemia
Feb 26, 2014 09:30 AM Ligand to Present at the 26th Annual Roth Conference on March 11
Feb 24, 2014 02:53 PM Form 10-K LIGAND PHARMACEUTICALS For: Dec 31
Feb 24, 2014 09:07 AM Ligand Pharma (LGND) Target Price Lifted to $91 at Summer Street
Feb 21, 2014 10:44 AM Form 4 LIGAND PHARMACEUTICALS For: Feb 20 Filed by: KNOTT DAVID M
Feb 20, 2014 08:01 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 18 Filed by: LAMPERT MARK N
Feb 19, 2014 12:17 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 14 Filed by: KNOTT DAVID M
Feb 14, 2014 08:20 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 12 Filed by: Aryeh Jason
Feb 14, 2014 08:19 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 12 Filed by: Sharp John P
Feb 14, 2014 08:06 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 12 Filed by: Berkman Charles S
Feb 14, 2014 08:05 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 12 Filed by: HIGGINS JOHN L
Feb 14, 2014 08:01 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 12 Filed by: FOEHR MATTHEW W
Feb 14, 2014 07:59 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 12 Filed by: DeSilva Nishan M
Feb 14, 2014 05:07 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: Park West Asset Management LLC
Feb 14, 2014 09:34 AM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: WELLINGTON MANAGEMENT CO LLP
Feb 14, 2014 06:54 AM Form SC 13G LIGAND PHARMACEUTICALS Filed by: FMR LLC
Feb 14, 2014 06:05 AM Form SC 13G LIGAND PHARMACEUTICALS Filed by: RS INVESTMENT MANAGEMENT CO LLC
Feb 12, 2014 10:07 AM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: VANGUARD GROUP INC
Feb 12, 2014 09:27 AM Summer Street Adjusts Model, Lifts PT on Ligand (LGND) to $79 Following Q4 Numbers
Feb 12, 2014 09:13 AM Cantor Fitzgerald Negative on Ligand Pharma (LGND) Reaction Post-Earnings
Feb 12, 2014 07:23 AM Roth Capital Lifts PT on Ligand (LGND) to $92; Still Sees Plenty of Positive Catalysts Ahead
Feb 11, 2014 08:36 AM Form 8-K LIGAND PHARMACEUTICALS For: Feb 11
Feb 11, 2014 08:32 AM Ligand Pharma (LGND) Tops Q4 EPS by 16c; Issues Light Q1 Outlook
Feb 11, 2014 08:30 AM Ligand Reports Fourth Quarter and Full Year 2013 Financial Results
Feb 10, 2014 04:15 PM Ligand to Receive $1 Million Kyprolis® Commercial Milestone Payment from Onyx Pharmaceuticals
Feb 6, 2014 12:09 PM Form SC 13G LIGAND PHARMACEUTICALS Filed by: BLAIR WILLIAM & CO/IL
Feb 3, 2014 09:55 AM Roth Keeps Ligand (LGND) at Buy; BD Indication for Promacta is Pleasant Surprise
Feb 3, 2014 07:32 AM Ligand Pharma (LGND) Reports Glaxo (GSK) Granted Breakthrough Designation by FDA for Promacta/Revolade
Feb 3, 2014 07:30 AM Ligand Partner GlaxoSmithKline Gains FDA Breakthrough Therapy Designation for Promacta®/Revolade® for Severe Aplastic Anemia
Jan 31, 2014 09:36 AM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BlackRock Inc.
Jan 29, 2014 04:15 PM Ligand to Report Fourth Quarter Results on February 11th
Jan 29, 2014 04:12 PM Form 8-K LIGAND PHARMACEUTICALS For: Jan 23
Jan 27, 2014 09:27 AM Ligand Pharma (LGND) Price Target Raised to $78 at Summer Street
Jan 21, 2014 08:04 PM Form 4 LIGAND PHARMACEUTICALS For: Jan 16 Filed by: HIGGINS JOHN L
Dec 31, 2013 03:46 PM Summer Street Research 2014 'Alpha List' Includes: NPS Pharmaceuticals (NPSP), Rockwell Medical (RMTI) and Others
Dec 4, 2013 06:10 AM Ligand Pharma (LGND) Boosts Q4, FY13 Outlook

Back to LGND Stock Lookup